Josh Lewis, PhD Joins Life Science Partner as Executive Search Associate


Life Science Partner is pleased to announce the addition of our newest team member, Josh Lewis, PhD. Josh joins us as Executive Search Associate and is responsible for managing our search operations and firm operations, including our research programs and technology platforms.

“Josh brings an additional layer of scientific and technological expertise to the Life Science Partner team,” states Tom Callaway, MD, Founder and President. “We are delighted to have Josh onboard to help us continue to deliver on our promise of a premium, scientifically expert, technology-driven executive recruiting service.”

Prior to joining LSP, Josh earned his PhD in Biochemistry, Cell and Developmental Biology from Emory University in Atlanta, where his research focused on cell adhesion molecules and cell membrane composition, with clinical applications ranging from oncology to rare skin diseases.

Josh applies his rigorous scientific training to our search process, building upon our clinical expertise and our carefully executed, partner-led process. As a scientist and engineer, Josh understands the technologies and market forces that are important to our clients. He also applies his training in complex research endeavors to ensure our identification and assessment of candidates reflect a level of intellectual rigor unmatched in the industry.

We also are pleased to leverage Josh’s technology background and coding skills, combined with the latest developments in data management and artificial intelligence, to continually reimagine how we use technology to magnify our networks and improve our service.

During graduate school, Josh lead the Emory Science Advocacy Network, which promotes the interests of the biomedical research community to Congress. Josh earned his PhD from Emory University in Atlanta and his undergraduate degree in Biological Engineering from the University of Georgia. Josh enjoys photography, hiking, and public policy.



Recruiting Transformational Leaders™

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Deva Puranam, MSc, MBA, Joins Baxter International as Vice President, Global Laboratory Operations

Former Senior Director, Global Quality Operations Mylan Pharmaceuticals

Life Science Partner recruited Deva Puranam, MSc, MBA, to serve as Vice President, Global Laboratory Operations at Baxter International to lead the company’s laboratory standardization practices and build out quality systems infrastructure across Baxter’s lab facilities worldwide.

Puranam joins Baxter after serving as Senior Director, Global Quality Operations for Mylan where he was responsible for implementing seamless harmonization for laboratory operational processes overseeing a team of 109 employees spanning across 33 manufacturing sites globally.

“With an enthusiastic communication style that underlies a highly competent individual who can win the respect of others, Puranam will be successful at building the next generation of quality managers at Baxter while improving quality assurance initiatives to exceed regulatory agency inspections worldwide,” states Tom Callaway, MD, Founder and President of Life Science Partner.

Puranam earned his Bachelor’s Degree in Mathematics, Physics and Chemistry and his Master of Science Degree in Organic Chemistry from Andhra University in India in 1991 and 1995. He completed his MBA in Marketing and Management Information Systems (Operations Research Ancillary) from the University of Madras.

Conner Childers, JD, Joins Beckman Coulter as Vice President, Head of Global Compliance

Former Healthcare Compliance Policy Director at Amgen

Life Science Partner partnered with Beckman Coulter to recruit Conner Childers, JD, to serve as Vice President, Head of Global Compliance for Beckman Coulter.  He will report to Curt Brueske, JD, General Counsel.

In his most recent role at Amgen, Childers had direct responsibility for building the compliance program so that the company was prepared to respond to the company’s first Corporate Integrity Agreement.  Working across Amgen’s U.S. operations, Childers recruited and led a team that made compliance part of the corporate commercial objectives.

With his Amgen experience in building new compliance programs in partnership with business units, Childers has the right balance of leadership and influence to build an effective Beckman Coulter compliance organization,” states Tom Callaway, MD, Founder and President of Life Science Partner. “His legal and organizational background including a career as a Naval Officer have given him the skills and ability to build and lead world class teams.”

Childers earned his Bachelor of Arts Degree in Government from Claremont McKenna College and his Juris Doctorate from the University of Arizona, College of Law.


Jeremy Miller, MD, Joins EndoChoice as Pathology Director

Former Director of Urologic Pathology/GI Pathology at Ameripath

Life Science Partner has recruited Jeremy Miller, MD, to lead the Pathology Lab at EndoChoice, a College of American Pathology (CAP) accredited lab focused on providing the highest level of quality and service to the GI community.

Miller joins EndoChoice after serving as Director of Urologic Pathology and GI Pathology at Ameripath, in addition to formerly serving as Chief Medical Officer for Platinum Pathology, a national GI and GU lab owned by Miller based out of Virginia.

“Miller has excellent training as a pathologist with broad surgical pathology training, he has worked directly under internationally-renowned Dr. Fenoglio-Preiser, one of the top GI leaders in the field,” states Tom Callaway, MD, President and Founder of Life Science Partner.  “He is an entrepreneurial leader in the field of high volume pathology with a can-do attitude that will fit with the corporate culture of EndoChoice.”

Miller earned a Bachelor of Science Degree in Engineering from Duke University and his MD from the Medical College of Georgia.  Miller completed his Fellowship in Genitourinary Surgical Pathology from the The Johns Hopkins Hospital.

Joe Jimenez Joins TissueTech as Vice President, Quality Assurance and Regulatory Affairs

Former Vice President, PGT Quality Teva Pharmaceuticals

Joe Jimenez, Vice President, formerly PGT Quality for Teva Pharmaceuticals has recently become Vice President, Quality Assurance and Regulatory Affairs for TissueTech, a Miami-based company producing regenerative amniotic tissue-based products for use in the ophthalmology, optometry, musculoskeletal and wound care markets.    Life Science Partner partnered with CEO Amy Tseng and founder Shefferd Tseng, MD, PhD, to recruit Jimenez to prepare the company for the changing regulatory landscape of regenerative medicine products.

At Teva, Jimenez was responsible for leading the global quality team for the PGT joint venture between Proctor & Gamble and Teva where he oversaw an international team based in Switzerland.  “Jimenez has global view of quality,” states Tom Callaway, MD, Founder and President of Life Science Partner.  “He has a broad hands-on approach to developing analytical methods and quality systems combined with a can-do energy that will mesh well with the culture at TissueTech.”

Jimenez earned a Bachelor of Arts degree in Chemistry from Queens College in New York.

Susan Blank Joins BioConfirm Laboratories as Chief Medical Officer

Founder and Chief Medical Officer of Atlanta Healing Center and President of the Georgia Society of Addiction Medicine
Life Science Partner is pleased to announce the recruitment of Susan Blank, MD, Founder and Chief Medical Officer for the Atlanta Healing Center to become the Chief Medical Officer for BioConfirm Laboratories-a new company based in Atlanta committed to providing personalized physician-led solutions and services for patients and clinicians surrounding addiction and substance abuse.

With her entire career focused on the treatment of addiction and behavioral health with a true passion for healing through comprehensive programs, Life Science Partner identified Blank as a key expert for establishing the therapy platform at BioConfirm.

As an active expert and advocate for addiction recovery, Blank can be heard nationwide every Tuesday on her weekly radio show “Detailing Addiction” on America’s Web Radio. “Her passion, enthusiasm, and in depth knowledge of comprehensive addiction therapy will be a major asset to BioConfirm’s growth,” states Tom Callaway, President and Founder of Life Science Partner.

Blank earned her Bachelor of Arts degree in Psychology from Augusta College and she completed her MD from the Medical College of Georgia.

Robert Rajalingam Joins Smiths Medical as VP, Global Product Management, Vascular Access

Former Site Leader and Vice President for Global Marketing at Medtronic/Covidien Vascular Therapies

As a medical device leader and strategic marketing executive, Robert Rajalingam has been selected to lead Smith Medical’s $300 M Vascular Access business.  Life Science Partner collaborated closely with Vice President, Carl Stamp to recruit Rajalingam from Medtronic.

Vascular medicine has been his passion and interest, having worked both in the venous therapy area (spearheading the re-branding with Rethink Varicose Veins campaign including an Olympic spokesperson at Covidien) and in arterial disease at Medtronic Vascular in business development, including a partnership with Abbott Vascular.

“Robert is passionate and articulate about medical devices and their ability to improve patient lives. Experienced in managing a maturing product portfolio while simultaneously spearheading product innovation, he has the know-how, tenacity, and marketing instincts to build highly effective teams at Smiths Medical,” states Tom Callaway, MD, Founder and President of Life Science Partner.

Rajalingam earned his Bachelor of Science in Engineering degree from Duke University and his MBA from Stanford Graduate School of Business.



Susan Alpert, MD, PhD joins Canary Medical as Regulatory Affairs Leader

Former Senior Vice President, Chief Regulatory Officer at Medtronic

As one of the foremost leaders in the complex regulatory arena of medical devices, combination products, and healthcare information, Susan Alpert, MD, PhD, has been recruited by Life Science Partner to serve as the top regulatory advisor for Canary Medical.

Canary Medical has established an innovative portfolio of intellectual property surrounding its CHIRP (Canary Medical Implantable Recording Processor) technology that is transforming the medical field as it allows medical device manufacturers to integrate a 1cc implanted device for wireless data transmission.

“As a seasoned expert within the inner workings of the FDA on healthcare data and appropriate management of patient information, the regulatory role at Canary will be a natural fit for Alpert following her retirement from Medtronic,” states Tom Callaway, MD, President of Life Science Partner.  “Alpert will be an invaluable source for Canary’s rapidly growing company and current leadership team- Bill Hunter, CEO and Jeff Gross, CTO.

Susan completed her bachelor’s degree at Barnard College, Columbia University in New York City and holds a master’s degree and Ph.D. in Biomedical Sciences from New York University. She received her medical degree from the University of Miami (Florida) and completed her clinical training at Montefiore Medical Center in the Bronx, New York and at Children’s National Medical Center in Washington, D.C.

Reggie Groves Discusses REVA’s New Bioresorbable Stent

Congratulations to REVA Medical CEO and former Life Science Partner placement Reggie Groves on her feature in this week’s San Diego Business Journal!

View the feature here.

Bill Bold Joins Vestagen Technical Textiles as Chief Executive Officer

Former President and Chief Executive Officer of Vascular Pathways

Life Science Partner has recruited Bill Bold, former CEO of Vascular Pathways and senior medical device leader, to become Chief Executive Officer for Vestagen, an innovator in the development of Active Barrier fabrics and protection technology to protect the healthcare worker.

Prior to joining Vestagen, Bold turned around Vascular Pathways with product innovation and commercialization and sold the company to CR Bard for its best-in-class portfolio of peripheral vascular access technologies. “Bold is an articulate, strategic and a strong leader who recruits world-class teams to early-stage companies,” stated Tom Callaway, MD, Founder and President of Life Science Partner and Venture Partner at HealthQuest Capital, an investor in the company.

“With a track record for delivering a strong return on investment in fundraising with venture capital and private equity, Bold has the experience to lead Vestagen’s growth and profitability within the healthcare industry,” noted Callaway.

Prior to joining Vascular Pathways, Bold held executive leadership roles for both early stage and corporate divisions of medical device companies such as Access Scientific, Venetec, Medibuy and CR Bard.

Bold earned a Bachelor of Science Degree in Marketing from West Chester University.